Journal article
A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
- Abstract:
-
UNLABELLED: Cyclooxygenase-2 (COX-2) is associated with tumour promotion, inhibition of apoptosis, angiogenesis and metastasis. Celecoxib, a selective COX-2 inhibitor was investigated, in patients with clinically localized prostate cancer using immunohistochemistry. PATIENTS AND METHODS: Patients with cT1-2 prostate cancer (n=45) were randomized to celecoxib 400mg b.d. or no treatment for four weeks prior to radical prostatectomy. Histological sections of preoperative biopsy and matched radi...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Anticancer research
- Volume:
- 29
- Issue:
- 5
- Pages:
- 1483-1488
- Publication date:
- 2009-05-01
- EISSN:
-
1791-7530
- ISSN:
-
0250-7005
- Source identifiers:
-
414534
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:414534
- UUID:
-
uuid:373e5967-5b35-4ef3-91e4-17236bb5646d
- Local pid:
- pubs:414534
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2009
If you are the owner of this record, you can report an update to it here: Report update to this record